Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from Chorus Aviation ( (TSE:CHR) ).
Chorus Aviation Inc. reported a significant turnaround in its financial performance for the second quarter of 2025, with a net income of $32.4 million compared to a net loss of $180.6 million in the same period last year. The improvement is attributed to the sale of the RAL business, growth at Voyageur, and reduced corporate costs. The company also announced strategic moves such as acquiring Elisen & Associates Inc. to support future growth, delivering specialized aircraft for firefighting, and initiating a quarterly dividend to enhance shareholder value. Additionally, Chorus completed share buybacks and plans to redeem outstanding debentures to strengthen its balance sheet.
The most recent analyst rating on (TSE:CHR) stock is a Buy with a C$21.00 price target. To see the full list of analyst forecasts on Chorus Aviation stock, see the TSE:CHR Stock Forecast page.
Spark’s Take on TSE:CHR Stock
According to Spark, TipRanks’ AI Analyst, TSE:CHR is a Neutral.
Chorus Aviation’s stock score is influenced by its strong corporate actions and effective cash flow management. However, persistent profitability challenges and a negative valuation aspect due to ongoing losses weigh on the overall score. Technical indicators suggest potential for recovery, but caution is advised due to mixed signals.
To see Spark’s full report on TSE:CHR stock, click here.
More about Chorus Aviation
Chorus Aviation Inc. operates in the aviation industry, focusing on regional aviation services. The company provides a range of services including aircraft leasing, maintenance, repair and overhaul (MRO), and operates through subsidiaries like Voyageur and Jazz, with a significant partnership with Air Canada.
Average Trading Volume: 42,880
Technical Sentiment Signal: Buy
Current Market Cap: C$564.1M
For an in-depth examination of CHR stock, go to TipRanks’ Overview page.